Skip to search formSkip to main contentSkip to account menu

JPX gene

Known as: JUST PROXIMAL TO XIST, NONCODING RNA 183, ENOX 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised…
Background In ENSURE-AF study, edoxaban had similar efficacy and safety profile versus enoxaparin–warfarin (enox–warf) in… 
2020
2020
A novel Xist RNA-mediated chromosome inactivation model using a mouse artificial chromosome
To develop a mouse artificial chromosome (MAC) carrying the mouse Xist gene (X-inactive specific transcript; Xist-MAC) as a… 
2019
2019
Long Noncoding RNA Functionality Beyond Sequence: The Jpx Model: Commentary on "Functional Conservation of lncRNA JPX Despite Sequence and Structural Divergence" by Karner et al. (2019).
2018
2018
Identification of Long Non-Coding RNAs for Predicting Prognosis Among Patients with Thymoma.
BACKGROUND Thymoma is the most common primary anterior mediastinal neoplasm with a high recurrence rate. Long noncoding RNAs… 
2017
2017
Abstract 18190: Impact of Age and Gender on Clinical Outcomes in the Edoxaban versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Randomized Trial
Background: In the ENSURE-AF study (NCT 02072434), the oral factor Xa inhibitor edoxaban showed a similar efficacy and safety… 
2016
2016
Compatibility of Injectable Anticoagulant Agents in Ethanol; In Vitro Antibiofilm Activity and Impact on Polyurethane Catheters of Enoxaparin 400 U/mL in 40% v/v Ethanol
Background and Objectives Interdialytic lock solutions should maintain catheter patency and prevent catheter infections. We aimed… 
2013
2013
An experimental investigationof vapor neutralization and dissolution and of JPX fuel
2004
2004
Degree of Anticoagulation after One Subcutaneous and One Subsequent Intravenous Booster Dose of Enoxaparin: Implications for Patients with Acute Coronary Syndromes Undergoing Early Percutaneous…
AbstractBackground: Many cardiologists continue to be reluctant to utilize low-molecular-weight heparin in the treatment of… 
2002
2002
Head-to-head comparison of two different low-molecular-weight heparins in acute coronary syndrome: a single center experience.
Low-molecular-weight heparins (LMWH) of different types have yielded different results when used in the setting of unstable… 
1996
1996
Effects of dobutamine and enoximone on transmitral and pulmonary venous flow characteristics in patients with left ventricular dysfunction after coronary artery bypass grafting.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)